![Sarah Miksinski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sarah Miksinski
Conseiller Juridique Général chez GILEAD SCIENCES, INC.
Postes actifs de Sarah Miksinski
Sociétés | Poste | Début | Fin |
---|---|---|---|
GILEAD SCIENCES, INC. | Conseiller Juridique Général | - | - |
International Society for Pharmaceutical Engineering
![]() International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Sarah Miksinski
Anciens postes connus de Sarah Miksinski
Sociétés | Poste | Début | Fin |
---|---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Etats-Unis | 3 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
General Counsel | 1 |
Sectorielle
Health Technology | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
International Society for Pharmaceutical Engineering
![]() International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
- Bourse
- Insiders
- Sarah Miksinski
- Expérience